Inhaled Imatinib for Pulmonary Arterial Hypertension
A drug-device combination product candidate in Phase 1 for the treatment of pulmonary arterial hypertension
We use cookies to offer you a better browsing experience, including personalized advertising. By continuing to use the site you agree to their use.